PureTech Health (NASDAQ:PRTC) Trading 3.5% Higher – Still a Buy?

PureTech Health plc (NASDAQ:PRTC)’s stock price was up 3.5% on Monday . The stock traded as high as $16.82 and last traded at $17.30. Approximately 650 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 3,900 shares. The stock had previously closed at $16.71.

PureTech Health Trading Up 3.5 %

The stock has a 50-day moving average price of $18.22 and a 200-day moving average price of $19.69.

Institutional Investors Weigh In On PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. Millennium Management LLC purchased a new position in PureTech Health plc (NASDAQ:PRTC) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 45,264 shares of the company’s stock, valued at approximately $823,000. Millennium Management LLC owned about 0.19% of PureTech Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.04% of the company’s stock.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.